ID   GNA11_HUMAN             Reviewed;         359 AA.
AC   P29992; O15109; Q14350; Q6IB00;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   05-OCT-2016, entry version 165.
DE   RecName: Full=Guanine nucleotide-binding protein subunit alpha-11;
DE            Short=G alpha-11;
DE            Short=G-protein subunit alpha-11;
DE   AltName: Full=Guanine nucleotide-binding protein G(y) subunit alpha;
GN   Name=GNA11; Synonyms=GA11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=1902575; DOI=10.1073/pnas.88.9.3907;
RA   Jiang M., Pandey S., Tran V.T., Fong H.K.W.;
RT   "Guanine nucleotide-binding regulatory proteins in retinal pigment
RT   epithelial cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:3907-3911(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Bai X.H., Acharya R., Bai Y.H., Murtagh J.J.;
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 42-52 AND 159-166, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Calvo F., Kolch W.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 244-337.
RC   TISSUE=Hematopoietic;
RX   PubMed=7492305; DOI=10.1042/bj3120151;
RA   Thomas C.P., Dunn M.J., Mattera R.;
RT   "Ca2+ signalling in K562 human erythroleukaemia cells: effect of
RT   dimethyl sulphoxide and role of G-proteins in thrombin- and
RT   thromboxane A2-activated pathways.";
RL   Biochem. J. 312:151-158(1995).
RN   [9]
RP   INTERACTION WITH RGS22, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=18703424; DOI=10.1095/biolreprod.107.067504;
RA   Hu Y., Xing J., Chen L., Guo X., Du Y., Zhao C., Zhu Y., Lin M.,
RA   Zhou Z., Sha J.;
RT   "RGS22, a novel testis-specific regulator of G-protein signaling
RT   involved in human and mouse spermiogenesis along with GNA12/13
RT   subunits.";
RL   Biol. Reprod. 79:1021-1029(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   INTERACTION WITH NTSR1.
RX   PubMed=21725197; DOI=10.4161/cbt.12.5.15984;
RA   Heakal Y., Woll M.P., Fox T., Seaton K., Levenson R., Kester M.;
RT   "Neurotensin receptor-1 inducible palmitoylation is required for
RT   efficient receptor-mediated mitogenic-signaling within structured
RT   membrane microdomains.";
RL   Cancer Biol. Ther. 12:427-435(2011).
RN   [12]
RP   PALMITOYLATION AT CYS-9 AND CYS-10.
RX   PubMed=21044946; DOI=10.1194/jlr.D011106;
RA   Forrester M.T., Hess D.T., Thompson J.W., Hultman R., Moseley M.A.,
RA   Stamler J.S., Casey P.J.;
RT   "Site-specific analysis of protein S-acylation by resin-assisted
RT   capture.";
RL   J. Lipid Res. 52:393-398(2011).
RN   [13]
RP   DEAMIDATION AT GLN-209 (MICROBIAL INFECTION).
RX   PubMed=24141704; DOI=10.1038/nsmb.2688;
RA   Jank T., Bogdanovic X., Wirth C., Haaf E., Spoerner M., Boehmer K.E.,
RA   Steinemann M., Orth J.H., Kalbitzer H.R., Warscheid B., Hunte C.,
RA   Aktories K.;
RT   "A bacterial toxin catalyzing tyrosine glycosylation of Rho and
RT   deamidation of Gq and Gi proteins.";
RL   Nat. Struct. Mol. Biol. 20:1273-1280(2013).
RN   [14]
RP   VARIANTS HYPOC2 CYS-60 AND TRP-211.
RX   PubMed=23782177; DOI=10.1056/NEJMp1302941;
RA   Memtsoudis S.G., Besculides M.C., Mazumdar M.;
RT   "A rude awakening--the perioperative sleep apnea epidemic.";
RL   N. Engl. J. Med. 368:2352-2353(2013).
RN   [15]
RP   VARIANTS HHC2 GLN-135 AND ILE-200 DEL, VARIANTS HYPOC2 GLN-181 AND
RP   LEU-341, CHARACTERIZATION OF VARIANTS HHC2 GLN-135 AND ILE-200 DEL,
RP   AND CHARACTERIZATION OF VARIANTS HYPOC2 GLN-181 AND LEU-341.
RX   PubMed=23802516; DOI=10.1056/NEJMoa1300253;
RA   Nesbit M.A., Hannan F.M., Howles S.A., Babinsky V.N., Head R.A.,
RA   Cranston T., Rust N., Hobbs M.R., Heath H. III, Thakker R.V.;
RT   "Mutations affecting G-protein subunit alpha11 in hypercalcemia and
RT   hypocalcemia.";
RL   N. Engl. J. Med. 368:2476-2486(2013).
CC   -!- FUNCTION: Guanine nucleotide-binding proteins (G proteins) are
CC       involved as modulators or transducers in various transmembrane
CC       signaling systems. Acts as an activator of phospholipase C.
CC   -!- SUBUNIT: G proteins are composed of 3 units; alpha, beta and
CC       gamma. The alpha chain contains the guanine nucleotide binding
CC       site. Interacts with RGS22. Interacts with NTSR1.
CC       {ECO:0000269|PubMed:18703424, ECO:0000269|PubMed:21725197}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305|PubMed:18703424};
CC       Lipid-anchor {ECO:0000305|PubMed:18703424}. Cytoplasm
CC       {ECO:0000269|PubMed:18703424}. Note=In testicular cells, expressed
CC       exclusively in the cytoplasm.
CC   -!- TISSUE SPECIFICITY: Expressed in testis.
CC       {ECO:0000269|PubMed:18703424}.
CC   -!- PTM: (Microbial infection) Deamidated at Gln-209 by Photorhabdus
CC       asymbiotica toxin PAU_02230, blocking GTP hydrolysis of
CC       heterotrimeric GNAQ or GNA11 and G-alphai (GNAI1, GNAI2 or GNAI3)
CC       proteins, thereby activating RhoA. {ECO:0000269|PubMed:24141704}.
CC   -!- DISEASE: Hypocalciuric hypercalcemia, familial 2 (HHC2)
CC       [MIM:145981]: A form of hypocalciuric hypercalcemia, a disorder of
CC       mineral homeostasis that is transmitted as an autosomal dominant
CC       trait with a high degree of penetrance. It is characterized
CC       biochemically by lifelong elevation of serum calcium
CC       concentrations and is associated with inappropriately low urinary
CC       calcium excretion and a normal or mildly elevated circulating
CC       parathyroid hormone level. Hypermagnesemia is typically present.
CC       Affected individuals are usually asymptomatic and the disorder is
CC       considered benign. However, chondrocalcinosis and pancreatitis
CC       occur in some adults. {ECO:0000269|PubMed:23802516}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Hypocalcemia, autosomal dominant 2 (HYPOC2) [MIM:615361]:
CC       A form of hypocalcemia, a disorder of mineral homeostasis
CC       characterized by blood calcium levels below normal, and low or
CC       normal serum parathyroid hormone concentrations. Disease
CC       manifestations include hypocalcemia, paresthesias, carpopedal
CC       spasm, seizures, hypercalciuria with nephrocalcinosis or kidney
CC       stones, and ectopic and basal ganglia calcifications.
CC       {ECO:0000269|PubMed:23782177, ECO:0000269|PubMed:23802516}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the G-alpha family. G(q) subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GNA11ID43272ch19p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M69013; AAA58624.1; -; mRNA.
DR   EMBL; AF011497; AAB64303.1; -; mRNA.
DR   EMBL; AF493900; AAM12614.1; -; mRNA.
DR   EMBL; CR457004; CAG33285.1; -; mRNA.
DR   EMBL; AC005262; AAC25615.1; -; Genomic_DNA.
DR   EMBL; BC089041; AAH89041.1; -; mRNA.
DR   EMBL; BC096225; AAH96225.1; -; mRNA.
DR   EMBL; BC096226; AAH96226.1; -; mRNA.
DR   EMBL; BC096227; AAH96227.1; -; mRNA.
DR   EMBL; L40630; AAA99949.1; -; mRNA.
DR   CCDS; CCDS12103.1; -.
DR   PIR; A39394; RGHUGY.
DR   RefSeq; NP_002058.2; NM_002067.4.
DR   UniGene; Hs.650575; -.
DR   UniGene; Hs.654784; -.
DR   ProteinModelPortal; P29992; -.
DR   SMR; P29992; 13-354.
DR   BioGrid; 109029; 35.
DR   IntAct; P29992; 6.
DR   MINT; MINT-4999662; -.
DR   STRING; 9606.ENSP00000078429; -.
DR   iPTMnet; P29992; -.
DR   SwissPalm; P29992; -.
DR   DMDM; 3041682; -.
DR   EPD; P29992; -.
DR   MaxQB; P29992; -.
DR   PaxDb; P29992; -.
DR   PeptideAtlas; P29992; -.
DR   PRIDE; P29992; -.
DR   Ensembl; ENST00000078429; ENSP00000078429; ENSG00000088256.
DR   GeneID; 2767; -.
DR   KEGG; hsa:2767; -.
DR   UCSC; uc010xhe.5; human.
DR   CTD; 2767; -.
DR   GeneCards; GNA11; -.
DR   HGNC; HGNC:4379; GNA11.
DR   HPA; HPA048886; -.
DR   MalaCards; GNA11; -.
DR   MIM; 139313; gene.
DR   MIM; 145981; phenotype.
DR   MIM; 615361; phenotype.
DR   neXtProt; NX_P29992; -.
DR   Orphanet; 428; Autosomal dominant hypocalcemia.
DR   Orphanet; 101049; Familial hypocalciuric hypercalcemia type 2.
DR   PharmGKB; PA28764; -.
DR   eggNOG; KOG0085; Eukaryota.
DR   eggNOG; ENOG410XNVQ; LUCA.
DR   GeneTree; ENSGT00760000118851; -.
DR   HOGENOM; HOG000038729; -.
DR   HOVERGEN; HBG063184; -.
DR   InParanoid; P29992; -.
DR   KO; K04635; -.
DR   OMA; CCISEEA; -.
DR   OrthoDB; EOG091G0VUT; -.
DR   PhylomeDB; P29992; -.
DR   TreeFam; TF300673; -.
DR   Reactome; R-HSA-399997; Acetylcholine regulates insulin secretion.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   Reactome; R-HSA-418592; ADP signalling through P2Y purinoceptor 1.
DR   Reactome; R-HSA-428930; Thromboxane signalling through TP receptor.
DR   Reactome; R-HSA-434316; Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion.
DR   Reactome; R-HSA-456926; Thrombin signalling through proteinase activated receptors (PARs).
DR   SIGNOR; P29992; -.
DR   ChiTaRS; GNA11; human.
DR   GeneWiki; GNA11; -.
DR   GenomeRNAi; 2767; -.
DR   PRO; PR:P29992; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000088256; -.
DR   CleanEx; HS_GNA11; -.
DR   ExpressionAtlas; P29992; baseline and differential.
DR   Genevisible; P29992; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0001750; C:photoreceptor outer segment; ISS:AgBase.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW.
DR   GO; GO:0031826; F:type 2A serotonin receptor binding; IBA:GO_Central.
DR   GO; GO:0001508; P:action potential; IBA:GO_Central.
DR   GO; GO:0071467; P:cellular response to pH; IEA:Ensembl.
DR   GO; GO:0048066; P:developmental pigmentation; IEA:Ensembl.
DR   GO; GO:0009649; P:entrainment of circadian clock; ISS:AgBase.
DR   GO; GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; ISS:AgBase.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007603; P:phototransduction, visible light; ISS:AgBase.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0045634; P:regulation of melanocyte differentiation; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   Gene3D; 1.10.400.10; -; 1.
DR   Gene3D; 3.40.50.300; -; 2.
DR   InterPro; IPR000654; Gprotein_alpha_Q.
DR   InterPro; IPR001019; Gprotein_alpha_su.
DR   InterPro; IPR011025; GproteinA_insert.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10218; PTHR10218; 1.
DR   Pfam; PF00503; G-alpha; 1.
DR   PRINTS; PR00318; GPROTEINA.
DR   PRINTS; PR00442; GPROTEINAQ.
DR   SMART; SM00275; G_alpha; 1.
DR   SUPFAM; SSF47895; SSF47895; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
PE   1: Evidence at protein level;
KW   ADP-ribosylation; Cell membrane; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; GTP-binding; Lipoprotein;
KW   Magnesium; Membrane; Metal-binding; Nucleotide-binding; Palmitate;
KW   Reference proteome; Transducer.
FT   CHAIN         1    359       Guanine nucleotide-binding protein
FT                                subunit alpha-11.
FT                                /FTId=PRO_0000203746.
FT   NP_BIND      46     53       GTP. {ECO:0000250|UniProtKB:P63096}.
FT   NP_BIND     180    186       GTP. {ECO:0000250}.
FT   NP_BIND     205    209       GTP. {ECO:0000250|UniProtKB:P63096}.
FT   NP_BIND     274    277       GTP. {ECO:0000250|UniProtKB:P63096}.
FT   METAL        53     53       Magnesium. {ECO:0000250}.
FT   METAL       186    186       Magnesium. {ECO:0000250}.
FT   BINDING     331    331       GTP; via amide nitrogen. {ECO:0000250}.
FT   MOD_RES     183    183       ADP-ribosylarginine; by cholera toxin.
FT                                {ECO:0000250}.
FT   MOD_RES     209    209       Deamidated glutamine; by Photorhabdus
FT                                PAU_02230. {ECO:0000269|PubMed:24141704}.
FT   LIPID         9      9       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:21044946}.
FT   LIPID        10     10       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:21044946}.
FT   VARIANT      60     60       R -> C (in HYPOC2; dbSNP:rs587777021).
FT                                {ECO:0000269|PubMed:23782177}.
FT                                /FTId=VAR_070165.
FT   VARIANT     135    135       L -> Q (in HHC2; induces a decrease in
FT                                sensitivity to changes in extracellular
FT                                calcium concentrations;
FT                                dbSNP:rs587777019).
FT                                {ECO:0000269|PubMed:23802516}.
FT                                /FTId=VAR_070166.
FT   VARIANT     181    181       R -> Q (in HYPOC2; induces an increase in
FT                                sensitivity to changes in extracellular
FT                                calcium concentrations;
FT                                dbSNP:rs587777020).
FT                                {ECO:0000269|PubMed:23802516}.
FT                                /FTId=VAR_070167.
FT   VARIANT     200    200       Missing (in HHC2; induces a decrease in
FT                                sensitivity to changes in extracellular
FT                                calcium concentrations).
FT                                {ECO:0000269|PubMed:23802516}.
FT                                /FTId=VAR_070168.
FT   VARIANT     211    211       S -> W (in HYPOC2; dbSNP:rs587777022).
FT                                {ECO:0000269|PubMed:23782177}.
FT                                /FTId=VAR_070169.
FT   VARIANT     341    341       F -> L (in HYPOC2; induces an increase in
FT                                sensitivity to changes in extracellular
FT                                calcium concentrations;
FT                                dbSNP:rs140749796).
FT                                {ECO:0000269|PubMed:23802516}.
FT                                /FTId=VAR_070170.
FT   CONFLICT      6      6       M -> I (in Ref. 2; AAB64303).
FT                                {ECO:0000305}.
FT   CONFLICT    266    266       N -> H (in Ref. 8; AAA99949).
FT                                {ECO:0000305}.
FT   CONFLICT    285    285       Y -> H (in Ref. 8; AAA99949).
FT                                {ECO:0000305}.
FT   CONFLICT    301    302       DA -> EP (in Ref. 1; AAA58624).
FT                                {ECO:0000305}.
FT   CONFLICT    310    310       L -> P (in Ref. 2; AAB64303).
FT                                {ECO:0000305}.
SQ   SEQUENCE   359 AA;  42123 MW;  DD37176589E66046 CRC64;
     MTLESMMACC LSDEVKESKR INAEIEKQLR RDKRDARREL KLLLLGTGES GKSTFIKQMR
     IIHGAGYSEE DKRGFTKLVY QNIFTAMQAM IRAMETLKIL YKYEQNKANA LLIREVDVEK
     VTTFEHQYVS AIKTLWEDPG IQECYDRRRE YQLSDSAKYY LTDVDRIATL GYLPTQQDVL
     RVRVPTTGII EYPFDLENII FRMVDVGGQR SERRKWIHCF ENVTSIMFLV ALSEYDQVLV
     ESDNENRMEE SKALFRTIIT YPWFQNSSVI LFLNKKDLLE DKILYSHLVD YFPEFDGPQR
     DAQAAREFIL KMFVDLNPDS DKIIYSHFTC ATDTENIRFV FAAVKDTILQ LNLKEYNLV
//
